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Kathryn B. Garber1,*Colon Cancer Risk Tied to Variation
in MYC Enhancer
Genome-wide association studies don’t necessarily point
to coding SNPs that immediately identify a gene of interest
and suggest some functionality. Sometimes, like in the case
of chromosome 8q24 and colorectal cancer (CRC), the SNP
of interest lies in a gene desert, which makes it a little less
obvious how the marker contributes to disease risk. Tuupa-
nen et al. and Pomerantz et al. were interested in the 8q24/
CRC association because it is estimated to make a very
strong contribution to CRC on a population level. Both
groups reasoned that the 8q24 SNPmight be in a regulatory
element forMYC because it is the closest documented gene
and it is known to participate in carcinogenesis. Indeed,
through a variety of techniques, the two groups show
that the SNP lies in a MYC enhancer that binds to the
TCF4/TCF7L2 transcription factor. In vitro assays suggest
that the CRC risk allele binds to TCF4 more strongly and
is more active in reporter assays. Tuupanen et al. also
ﬁnd that in individuals heterozygous for this SNP, tumor
samples exhibit preferential ampliﬁcation of segments of
chromosome 8q24 that contain the risk allele. The predic-
tion from these data is that the risk allele is associated with
increased MYC expression; unfortunately, neither group
could document an obvious difference in MYC expression
on the basis of genotype at this SNP.
Tuupanen et al. (2009). The common colorectal cancer
predisposition SNP rs6983267 at chromosome 8q24 confers
potential to enhanced Wnt signaling. Nature Genetics 41,
885–892.
Pomerantz et al. (2009). The 8q24 cancer risk variant
rs6983267 shows long-range interaction with MYC in colo-
rectal cancer. Nature Genetics 41, 882–884.
New Role for Phosphatidyl Inositol Signaling
in Regulation of Cilia
Through studies of several genetic disorders, our under-
standing of the role of nonmotile cilia in development
and in normal cell biology has greatly increased. One of
these so-called ciliopathies is Joubert syndrome, a rare auto-
somal-recessive disorder that includes hypotonia, episodes
of rapid breathing, ataxia, developmental delays, and the
‘‘molar-tooth sign,’’ a disease hallmark that can be seen byThe Americancranial MRI. Through extensive sequencing around the
JBTS1 locus in affected families, Bielas et al. ﬁnd an unex-
pected link between phosphatidyl inositol signaling and
the functionofnonmotile cilia. Theyﬁndmissense changes
in INPP5E in several families affected by Joubert syndrome.
The mutations cluster within the phosphatase domain of
the encoded protein, inositol polyphosphate-5-phospha-
tase E, and impair the phosphatase activity of the enzyme.
INPP5E localizes to cilia in the major organs affected by
Joubert syndrome, including the renal collecting tubules,
cerebellum, and retinal photoreceptor cells. Primary ﬁbro-
blasts from affected individuals are ciliated normally.
However, in response to serum stimulation in culture,
INPP5E appears to control rates of ciliary disassembly and
to affect the percentage of mitotically active cells. This is
the ﬁrst strong link suggesting that phosphatidyl inositol
signaling regulates the primary cilium.
Bielas et al. (2009). Mutations in INPP5E, encoding inositol
polyphosphate-5-phosphatase E, link phosphatidyl inositol
signaling to the ciliopathies. Nature Genetics, in press.
Published online August 9, 2009. 10.1038/ng.423.
Epistasis in Hirschsprung Disease
Hirschsprung disease (HSCR) is characterized by incom-
plete innervation of part of the gut. It can occur as an iso-
lated disease, but it has also been found in conjunction
with a variety of syndromes, including Bardet-Biedl
syndrome (BBS). The key gene for HSCR appears to be
RET; most people with isolated HSCR are heterozygous
for a RET mutation or hypomorphic allele. However, the
penetrance of HSCR is reduced, and variation at genes
other than RET inﬂuences disease expression. de Pontual
et al. wondered whether variation at multiple genes also
contributes to the appearance of HSCR in the context of
a syndrome. They identiﬁed families with both BBS and
HSCR and found that penetrance of HSCR seemed to be
inﬂuenced by variation in RET. In a zebraﬁsh model,
they show that whereas suppression of one of the bbs genes
or ret individually reduces enteric neuron migration,
suppression of ret in combination with a bbs gene results
in a much more severe defect. The BBS proteins localize
to cilia and basal bodies, whereas RET is a cell-surface
receptor. No evidence links the activities of these proteins
thus far, and the authors do not suggest that one exists.1Department of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA
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Instead, they propose that perturbation of two separate
signaling systems happens to converge at the level of
neuronal migration and survival in the gut and that the
effects of these perturbations together are enough to
prevent proper innervation of the gut.
de Pontual et al. (2009). Epistasis between RET and BBS
mutations modulates innervation and causes syndromic
Hirschsprung disease. PNAS Early Edition, in press. Published
online July 31, 2009. 10.1073/pnas.0901219106.
Can IGF-1 Be Used to Treat Spinal
and Bulbar Muscular Atrophy?
Although there are differences in the neurons that are
affected and the speciﬁcs of the phenotypes that are
produced, the polyglutamine diseases are all characterized
by neurotoxicity that is associated with the formation of
aggregates of the polyglutamine-containing protein. The
polyglutamine expansion causing spinal and bulbar
muscular atrophy (SBMA) occurs in the androgen receptor
(AR). Normally, the AR binds its ligand, is internalized, and
translocates to the nucleus. In the context of polyglut-
amine-containing AR, this nuclear localization is required
for SBMA disease pathogenesis, which ultimately leads to
loss of lower motor neurons in the brainstem and spinal
cord but is preceded by pathology to the skeletal muscle.
Knowing that AR could be inactivated through phosphor-
ylation by Akt, which itself lies in a pathway that is stimu-
lated by insulin-like growth factor 1 (IGF-1), Palazzolo et al.
decide to see whether manipulation of these signaling
pathways could be used to modify the outcome of SBMA
in a mouse model. First, in cell culture, they demonstrate
that, in an Akt-dependent fashion, IGF-1 reduces aggrega-
tion of mutant AR and increases degradation of AR
through the proteasome. Then, in a mouse model of
SBMA, they ﬁnd that overexpression of a muscle-speciﬁc
isoform of IGF-1 delays disease onset, increases the disease
duration and lifespan, and reduces the pathology in the
muscle and spinal cord of affected mice. Although IGF-1 it-
self promotes muscle growth, the amelioration of disease
in SBMA mice does not solely occur by overstimulating
muscle; the growth factor also reduces AR aggregate forma-
tion and motor neuron loss in affected mice. IGF-1 is thus
a candidate therapy for SBMA and could also prove useful
for other diseases that lead to muscle atrophy.
Palazzolo et al. (2009). Overexpression of IGF-1 in muscle
attenuates disease in a mouse model of spinal and bulbar
muscular atrophy. Neuron 63, 316–328.
Identification of Loci that Govern
Cell-Type-Specific Gene Expression
The gene-expression pattern for each speciﬁc cell type is
what gives a cell its unique properties. We recognize
some of the general and even some of the speciﬁc regula-
tory sequences controlling gene expression, but there is306 The American Journal of Human Genetics 85, 305–307, Septemstill a lot to know, particularly in the realm of cell-type-
speciﬁc gene expression. Many of the studies that have
looked for genetic-variation-inﬂuencing gene expression
(eQTLs) have been based on measurements of mRNA tran-
script levels from one cell type per individual in the study.
To look more speciﬁcally at tissue-speciﬁc control of gene
expression, Dimas et al. performed genetic association
studies for eQTLs by using three cell types from each indi-
vidual in the study. This was made possible by umbilical
cord blood sampling, which yielded primary ﬁbroblasts,
lymphoblastoid cell lines, and T cells for testing. The
authors searched for cis regulatory elements by testing for
genetic associations between gene expression level and
all SNPs within a 2 Mb window around the transcription
start site for that gene. The majority of eQTLs that they
found, nearly 80%, were cell-type speciﬁc. However, that
did not mean that gene expression was restricted to one
cell type; it appeared that many of the genes were ex-
pressed in all three cell types but that regulatory elements
were used in a cell-type-speciﬁc manner to tweak the level
of expression. Beyond inﬂuencing the transcript level for
an individual cell type, Dimas et al. speculate that eQTLs
might also inﬂuence alternative transcript choice because
the number of eQTLs per gene correlates with the number
of transcripts per gene. Clearly, we have a lot more to learn
about the genetic variation that controls gene expression,
and it is crucial that tissue-speciﬁc expression be taken
into account in these studies as they move forward.
Dimas et al. (2009). Common regulatory variation impacts
gene expression in a cell-type dependent manner. Science
Express, in press. Published online July 31, 2009. 10.1126/
science/1174148.
This Month in Our Sister Journals
Should Population-Wide Testing
for BRCA1/2 Mutations be Pursued?
A key component to decision-making algorithms for
BRCA1/2 mutation testing is family history. The fact is
that a signiﬁcant percentage of BRCA1/2 mutation carriers
with no family history will go on to have breast or ovarian
cancer. Would a population-based genetic screening
program be an effective way to detect these carriers with
no family history? This is the question explored by Rubin-
stein et al. They modeled the effectiveness of a population-
based screening program for BRCA1/2 founder mutations
in the U.S. Ashkenazi Jewish population in terms of its
effects on ovarian cancer. Using data from the literature
on rates of uptake for screening programs and for risk-
reducing surgery in BRCA1/2 mutation carriers, they esti-
mate that over 2800 cases of ovarian cancer could be
prevented through such a screening program and that
life expectancy in carriers would be increased by almost
1.5 years. The estimated costs of such a program are in
line with other public health interventions that are well
accepted. Although this study is limited by the fact thatber 11, 2009
breast cancer screening, prevention, and treatment were
not considered, the authors advocate for a dialog among
stakeholders as to whether such a population-based
screening program should be pursued.
Rubinstein et al. (2009). Cost-effectiveness of population-
based BRCA1/2 testing and ovarian cancer prevention for Ashke-
nazi Jews: A call for dialog. Genetics in Medicine, in press. Pub-
lished online July 14,2009. 10.1097/GIM.0b013e3181afd322.
Superoxide Radicals Paralyze Flies
Overproduction of superoxide radicals is toxic, as has been
observed in several model systems. Approximately 10 hr or
so after they emerge from the pupal case, Drosophila that
lack the superoxide dismutase Sod2 no longer move.
But—to steal a line from The Princess Bride—are they all
dead or only mostly dead? Godenschwege et al. ﬁnd thatThe Americanat times when the ﬂies are no longer mobile, they still
have normal sensory and motor neuron outputs, so
although they are alive, they just can’t move. The lack of
an early effect on neural transmission indicates that
muscle is more sensitive to the effects of superoxide radi-
cals than are neurons. This is further supported by the
ﬁnding that muscle-speciﬁc, but not neuron-speciﬁc,
expression of Sod2 prolongs the lifespan and mobility of
these ﬂies. This work suggest that the ‘‘mostly-dead’’ Sod2
mutant ﬂies still have some life in them and that they
will be useful in further studies of the effects of superoxide
radicals on different tissues.
Godenschwege et al. (2009). Mitochondrial superoxide radi-
cals differentially impact muscle activity and neural function.
Genetics, in press. Published online June 22, 2009. 10.1534/
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